This article examines the dual crisis of antimicrobial resistance in biology and governance, highlighting necessary interventions.
Antimicrobial resistance (AMR) represents one of the most formidable challenges to modern medicine and public health, simultaneously operating as a crisis of biological evolution and a crisis of international governance. On the biological front, bacteria deploy sophisticated evolutionary mechanisms—including horizontal gene transfer, mobile genetic elements, and biofilm formation—to circumvent antimicrobial agents. On the governance front, the global community struggles with fragmented policy implementation, inadequate funding, and stark disparities across human, animal, and environmental health sectors. This article examines AMR through the lens of this dual crisis, exploring how evolutionary pressures drive resistance emergence while governance failures allow these biological threats to proliferate unchecked. Drawing upon the recently updated Global Action Plan on Antimicrobial Resistance (2026–2036) and recent epidemiological forecasts, we argue that bridging the gap between evolutionary understanding and policy execution is essential for preserving antimicrobial efficacy for future generations.
No takes yet. Share an insight, caveat, or question.
ali et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: